SAMHD1: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
FrescoBot (talk | contribs)
added relevant references and improved text clarity
Line 1: Line 1:
{{Orphan|date=February 2009}}
{{Orphan|date=February 2009}}
{{PBB|geneid=25939}}
{{PBB|geneid=25939}}
'''SAM domain and HD domain-containing protein 1''' is a [[protein]] that in humans is encoded by the ''SAMHD1'' [[gene]]. SAMHD1 is responsible for blocking replication of [[HIV]] in [[dendritic cells]].<ref>{{cite journal|last=Laguette|first=Nadine|coauthors=et al.|title=SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx|journal=Nature|year=2011}}</ref> It is an [[enzyme]] that exhibits phosphohydrolase activity,<ref> {{cite pmid|22056990}}</ref> converting [[nucleotide triphosphates|nucleotide triphosphate]]s to a [[nucleoside]] and triphosphate. In doing so, it depletes to pool of nucleotides available for [[DNA]] synthesis by [[reverse transcriptase]] and so prevents viral replication.<ref name="pmid22327569">{{cite journal | author = Lahoussa ''et al.'' | title = SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates | journal = Nature Immunology | volume = 13 | issue = | pages = 223-228 | year = 2012 | month = | pmid = 22327569 | doi = 10.1038/ni.2236 }}</ref>
'''SAM domain and HD domain-containing protein 1''' is a [[protein]] that in humans is encoded by the ''SAMHD1'' [[gene]]. SAMHD1 is responsible for blocking replication of [[HIV]] in [[dendritic cells]]<ref>{{cite journal|last=Laguette|first=N.|coauthors=et al.|title=SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx|journal=Nature|year=2011|pmid=21613998}}</ref>, [[macrophages]]<ref>{{cite journal|last=Hrecka|first=K.|coauthors=et al.|title=Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein|journal=Nature|year=2011|pmid=21720370}}</ref>and [[monocytes]]<ref>{{cite journal|last=Berger|first=A.|coauthors=et al.|title=SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection|journal=PLoS Phatog.|year=2011|pmid=22174685}}</ref>. It is an [[enzyme]] that exhibits phosphohydrolase activity<ref> {{cite pmid|22056990}}</ref>, converting [[nucleotide triphosphates|nucleotide triphosphate]]s to a [[nucleoside]] and triphosphate. In doing so, SAMHD1 depletes the pool of nucleotides available to a [[reverse transcriptase]] for viral c[[DNA]] synthesis and thus prevents viral replication<ref name="pmid22327569">{{cite journal | author = Lahoussa, H. ''et al.'' | title = SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates | journal = Nature Immunology | volume = 13 | issue = | pages = 223-228 | year = 2012 | month = | pmid = 22327569 | doi = 10.1038/ni.2236 }}</ref>.


==References==
==References==

Revision as of 15:55, 6 September 2012

Template:PBB SAM domain and HD domain-containing protein 1 is a protein that in humans is encoded by the SAMHD1 gene. SAMHD1 is responsible for blocking replication of HIV in dendritic cells[1], macrophages[2]and monocytes[3]. It is an enzyme that exhibits phosphohydrolase activity[4], converting nucleotide triphosphates to a nucleoside and triphosphate. In doing so, SAMHD1 depletes the pool of nucleotides available to a reverse transcriptase for viral cDNA synthesis and thus prevents viral replication[5].

References

  1. ^ Laguette, N. (2011). "SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx". Nature. PMID 21613998. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
  2. ^ Hrecka, K. (2011). "Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein". Nature. PMID 21720370. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
  3. ^ Berger, A. (2011). "SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection". PLoS Phatog. PMID 22174685. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
  4. ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 22056990, please use {{cite journal}} with |pmid=22056990 instead.
  5. ^ Lahoussa, H.; et al. (2012). "SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates". Nature Immunology. 13: 223–228. doi:10.1038/ni.2236. PMID 22327569. {{cite journal}}: Cite has empty unknown parameter: |month= (help); Explicit use of et al. in: |author= (help)

Further reading

External links